High proportions of individuals in both arms achieved virological success and there were significant increases in CD4 counts. Both arms had a remarkably low discontinuation rate compared with other studies. Individuals who received TDF had fewer toxicities associated with mitochondrial dysfunction, potentially secondary to a greater increase in mitochondrial DNA than those treated with d4T. In addition, the TDF arm had smaller increases in cholesterol and triglycerides.